Morning Bid: Uncertainty dominates ECB forum
A look at the day ahead in European and global markets from Rocky Swift
A central bank Who's Who is due to speak in Sintra, Portugal today as policymakers grapple with an uncertain landscape for trade, growth and inflation.
Uncertainty was the key theme in opening remarks from European Central Bank President Christine Lagarde on Monday at the ECB's annual forum for central bankers. Lagarde is scheduled to join a panel with central bank heads from the United States, Japan, Britain and South Korea at 1330 GMT.
And uncertainty remains over U.S. President Donald Trump's "One, Big, Beautiful Bill," which remains logjammed at the Senate. Trump is desperate to get it passed before America's "Independence Day" on July 4, while deadlines over his "Liberation Day" tariffs loom over trade negotiations.
Trump called Japan "spoiled" as a trade deal between the two nations remained elusive, and U.S. Treasury Secretary Scott Bessent warned that countries could be notified of sharply higher tariffs.
Except for Japan's Nikkei, equity markets were broadly higher in Asia, with benchmark indexes in South Korea and Taiwan climbing more than 1.4%. Fresh readings from the Bank of Japan's tankan index and China's Caixin PMI indicated Asia's biggest economies were weathering the tariff storm, at least for now.
Euro Stoxx 50 futures pointed to a flat opening, while German DAX futures were up about 0.1%. U.S. stock futures, the S&P 500 e-minis, were down 0.1%.
The euro continued its winning days, poised for a record 10th consecutive day of gains against the U.S. dollar, reaching $1.1808, the highest since September 2021.
Key developments that could influence markets on Tuesday:
- ECB's Sintra conference policy panel
- U.S. ISM manufacturing data for June
- Manufacturing Purchasing Managers Indexes (PMI) data for France, Germany, and Euro Zone for June
- UK house prices for June
Trying to keep up with the latest tariff news?
Our new daily news digest offers a rundown of the top market-moving headlines impacting global trade. Sign up for Tariff Watch here.
Error al recuperar los datos
Inicia sesión para acceder a tu cartera de valores
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
29 minutes ago
- Forbes
Stellantis Future Looks Positive After Capacity And Brand Cuts
Fiat Grande Panda battery electric compact car (Photo by Sjoerd van) Getty Images Stellantis, troubled owner of brands including Jeep, Chrysler, Peugeot, Alfa Romeo and Maserati, has lost about 55% of its stock market value over the past year. But with new leadership, some analysts believe the only way is up, despite some challenges which might require plant closures and the elimination of brands. Since the demise of former CEO Carlos Tavares and the assumption of Antonio Filosa there has been no shortage of rumours about strategy. Reports Stellantis would merge with Renault were denied. Storied but problematic luxury Italian sports carmaker Maserati is not for sale; yet. A year ago, the Stellantis share price was around €19. It closed near €8.50 June 30, according to Reuters data. Dynamic Chinese newcomers like Chery Automobile and BYD are said to be looking at buying brands like Chrysler. As trading conditions toughen in Europe and U.S. tariffs worry everyone, some factories might be closed, or some of the 14 brands eliminated. Stellantis was created in 2019 by the merger of Fiat Chrysler and PSA Group. Stellantis's financial numbers have been under pressure. Operating profit margin in 2024 was 5.5%, down sharply from 2023's 12.8%. Last year, industrial cash flow was a negative €6 billion ($6.8 billion) compared with 2023's positive €12.9 billion ($14.6 billion). In 2021, former CEO Tavares gave the 14 brands, 10 years to justify their existence. That deadline has certainly been shortened, although new CEO Filosa hasn't officially decided yet. In Europe, the mass-market brands - Citroen, Peugeot, Fiat, Lancia, Vauxhall, Opel - compete against each other. DS, Alfa Romeo and Abarth sit in the wannabe premium sector. In the U.S., there is Dodge, Ram, Jeep and Chrysler. Overall, Maserati sits atop of the list. In late June, Filosa talked about the Stellantis long-term strategic plan without adding any details. The plan adopted in 2022 aimed to double sales by the end of the decade and maintain double-digit operating margins. Some aspects of the plan have been overtaken by events, such as the aim for 100% of sales in Europe to be electric by 2030, and 50% in the U.S. Jeep Wrangler Rubicon. Photo taken in Telluride, Colorado. getty Moody's Ratings pointed to the underlying strength of Stellantis when it changed its outlook to 'stable' from 'negative' and said the company's strong cash balances were an important buffer in the current volatile and challenging market environment. Investment researcher Jefferies put it this way in a report entitled 'Jump-starting Stellantis – Upgrade to Buy'. Earnings slide about to turn 'Data suggests the earnings slide is about to turn. A new CEO can move fast on overdue decisions, from brands to footprint and technology. Autos look more challenged than ever, but many Stellantis operating issues are self-inflicted and fixable,' Jefferies said. 'Stellantis and predecessors never shied away from bold and creative capital allocation decisions. Restructuring costs are material but manageable. Gaining investor trust may take time,' the report said. A 2025 Maserati MC20 GT2 Stradale Photographer: Bing Guan/Bloomberg © 2025 Bloomberg Finance LP Jamel Taganza, vice-president of French automotive consultancy Inovev, said Stellantis sales in 2024 fell 12%, and a further 10% in the first four months of 2025. Many Stellantis factories are running at a slow pace and suffering from significant overcapacity. Its policy has been to keep factories open. 'Given these elements, the Stellantis Group will most likely be forced to implement a policy that breaks with the previous year's objectives, aided in this by the arrival of the new CEO. This could result in factory closures and brand purging. On the other hand, Stellantis could relaunch thermal and hybrid engines, and abandon a fully battery electric range, with the hope of a postponement of the 2035 (European Union) ban on thermal vehicles,' Taganza said in a report. Maserati future in question Taganza said DS, Lancia and Maserati have questionable futures. He doesn't expect any interest from the likes of BYD or Chery though. Meanwhile, Stellantis has bought a 21% stake in Leapmotor of China. Leapmotor initially was expected to assemble small cars like the TO3 in Poland. This plan stumbled because of import tariff complications. Leapmotor is currently sourcing its vehicles from outside Europe. Whatever changes are made to brand strategy, Taganza expects Stellantis to retain its position in Europe as the second biggest automaker in terms of sales, behind Volkswagen. 'We do not see major changes in the five coming years for Stellantis, in terms of position in the European market. They should still be the second group in Europe, despite the advance of Chinese carmakers. Chrysler 300 getty It will follow the trend of the European market without any big surprises,' Taganza said in an email. Chester Springs, Pennsylvania-based Auto Forecast Solutions analyst Sam Fiorani agrees action is urgent and expects a plan to do that in a couple of years. 'Keeping Ram, Jeep and Peugeot are the easiest decisions. Global growth of Ram and Jeep make them very important, especially with the revenue and profits generated by the entire range of models. Peugeot ranks as the sixth most popular brand in Europe and remains important in other global regions,' Fiorani said in a report. Consolidation by the end of the decade The future of other brands is less obvious, but consolidation among the mainstream brands is likely before the end of the decade. 'Fiat ranks as the automaker's second largest brand and remains popular in South America and, of course, Italy. Citroen and Opel/Vauxhall combine for about 1.8 million units by offering a similar range of vehicles primarily for different European markets, but with their own style and marketing; the three should be consolidated into one marketing group,' Fiorani said. Fiorani sees a huge task ahead for the new CEO, and like Inovev's Taganza, a healthy outcome. That's quite a prediction, given the burgeoning challenge from China. 'Antonio Filosa has a monumental task ahead. Plants will need to be closed, workforce reduced, even brands eliminated. Done with proper attention, the automaker should be able to retain most of its current global market share,' Fiorani said.
Yahoo
38 minutes ago
- Yahoo
3 Reasons BIIB is Risky and 1 Stock to Buy Instead
Over the past six months, Biogen's stock price fell to $125.58. Shareholders have lost 16.3% of their capital, which is disappointing considering the S&P 500 has climbed by 5.7%. This might have investors contemplating their next move. Is now the time to buy Biogen, or should you be careful about including it in your portfolio? Get the full stock story straight from our expert analysts, it's free. Despite the more favorable entry price, we're swiping left on Biogen for now. Here are three reasons why there are better opportunities than BIIB and a stock we'd rather own. A company's long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Biogen struggled to consistently generate demand over the last five years as its sales dropped at a 7.4% annual rate. This wasn't a great result and is a sign of lacking business quality. Forecasted revenues by Wall Street analysts signal a company's potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite. Over the next 12 months, sell-side analysts expect Biogen's revenue to drop by 6.9%, a decrease from its 7.4% annualized declines for the past five years. This projection is underwhelming and implies its products and services will face some demand challenges. Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions. Sadly for Biogen, its EPS declined by 15.1% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand. Biogen isn't a terrible business, but it doesn't pass our quality test. After the recent drawdown, the stock trades at 7.8× forward P/E (or $125.58 per share). While this valuation is optically cheap, the potential downside is big given its shaky fundamentals. We're fairly confident there are better stocks to buy right now. We'd recommend looking at a top digital advertising platform riding the creator economy. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Got $5,000? 3 Top Growth Stocks to Buy That Could Double Your Money.
Steris provides infection-prevention products and reports soaring net income on the back of consistent revenue growth. Mastercard is a market leader in secure payment processing and reports a steady climb in both revenue, net income, and dividends. Church & Dwight sells household and personal-care products, and sees growing demand that's pushing up revenue and net income. 10 stocks we like better than Mastercard › Investing in growth stocks is a proven way to increase your investment portfolio over the long term. By parking available funds, say $5,000, in strong, growing companies, and keeping it there long-term, you are likely to see the value of those investments rise steadily, generating the funds you need to finance your future lifestyle. Choosing the right mix of stocks for this $5,000 investment is important, and the companies they represent should ideally have strong business models and market share and enjoy long-term tailwinds that can raise their revenue, profits, and dividends over the years. Here are three attractive growth stocks that are worth a $5,000 investment. You might want to give them a closer look and perhaps even consider adding them to your portfolio. Steris (NYSE: STE) manufactures and sells products and services to support patient care, with a focus on infection prevention. In its latest fiscal year, the company derived 71% of revenue from its healthcare segment, which supplies products to operating rooms and endoscopy suites. Steris reports demand for its products has increased steadily over the years, resulting in consistent growth in revenue and net income (see chart below). Free cash flow also shot up in tandem with net income, allowing the patient-care provider to pay out rising dividends. Dividend per share increased from $0.52 a year ago to $0.57, a year-over-year increase of 9.6%. Metric 2023 2024 2025 Revenue $4.54 billion $5.14 billion $5.46 billion Operating income $791 million $836 million $867 million Net income $107 million $378 million $615 million Free cash flow $395 million $613 million $778 million Data source: Steris PLC. Fiscal years end March 31. Fiscal 2025 was a record year, and management put forth an optimistic outlook for fiscal 2026. Revenue is projected to increase by around 6% to 7% year over year, with adjusted earnings per share increasing by 7% to 10% over the same period. These numbers account for the negative impact of tariffs announced by President Donald Trump. The business also expects to generate positive free cash flow of around $770 million. Steris' long-term goal is to achieve annual revenue growth in the mid-to-high single digits. The rising demand for procedures will provide mid-single-digit growth, while the remaining growth will come from merger-and-acquisition opportunities that the company will source to boost its portfolio and capabilities. Over the long term, management is targeting double-digit adjusted earnings-per-share growth. The business's future seems assured as the global aging population is prompting a rising need for medical procedures, and Steris' products and services should see increased demand. Mastercard (NYSE: MA) operates a payment network that facilitates fast and secure payment transactions between merchants, banks, and customers through debit and credit cards. The company has a strong brand and 3.5 billion debit and credit cards circulating globally. It has also demonstrated steady growth in revenue, net income, and free cash flow over the years, as shown below. Metric 2022 2023 2024 Revenue $22.2 billion $25.1 billion $28.2 billion Operating income $12.3 billion $14 billion $15.6 billion Net income $9.9 billion $11.2 billion $12.8 billion Free cash flow $10.1 billion $10.9 billion $13.6 billion Data source: Mastercard. Fiscal years end Dec. 31. The earnings momentum has continued in the first quarter of 2025. Mastercard reported revenue of $7.3 billion, 14.2% higher than a year ago. Operating income climbed 15.1% year over year to $4.1 billion, while net income increased by nearly 9% year over year to $3.3 billion. Free cash flow surged by 56.3% year over year to $2 billion, illustrating Mastercard's ability to consistently generate excess cash that it can pay as dividends. The business recently paid out a quarterly dividend of $0.76, a 15% year-over-year increase, and has seen its quarterly dividend rise without fail since 2009. Mastercard continues to innovate with its offerings to enhance its competitive edge and keep customers loyal. Back in April, it launched agentic AI payments to enable more personalized and secure payment experiences for consumers, issuers, and merchants. It also partnered with Microsoft on uses for agentic commerce and is collaborating with IBM to explore business-to-business use cases. In June, Mastercard once again partnered with Fiserv to promote stablecoin adoption as a digital asset means of payment. These collaborations and innovations will strengthen Mastercard's business proposition and enhance its ecosystem further, allowing the business to continue posting higher revenue and net income in the years to come. Church & Dwight (NYSE: CHD) is a household and personal-care consumer products giant managing key brands such as Hero, Vitafusion, and Arm & Hammer. The company has grown its revenue, profits, and free cash flow over the years through a mix of organic growth and acquisitions. These numbers (in the chart below) show Church & Dwight's consistency in delivering results. Metric 2022 2023 2024 Revenue $5.38 billion $5.87 billion $6.12 billion Operating income $598 million $1.1 billion $807 million Net income $414 million $756 million $585 million Free cash flow $706 million $807 million $976 million Data source: Church & Dwight. Fiscal years end Dec. 31. The first quarter of 2025 saw revenue and net income dip slightly year over year by 2.4% and 3.3%, respectively, to $1.47 billion and $220.1 million. However, the business continued to churn out healthy free cash flow of $169.2 million for the quarter. Church & Dwight paid out a quarterly per-share dividend of $0.295, a slight increase over the previous year's $0.28375. The company has a proud history of 124 consecutive years of paying dividends and has seen its dividend increase without fail since 2009. Church & Dwight management said it believes the company still has a long growth runway. Currently, more than 70% of its sales and profits are generated by seven power brands. Some of its power brands, such as Hero and Therabreath, still have significant room for growth as household penetration remains low. The company recently added an eighth power brand, Touchland, after acquiring it for a total purchase price of up to $880 million. Touchland is the fastest-growing brand in the hand sanitizer category in the U.S. and will help to drive more growth for Church & Dwight. Innovation is another key driver of revenue growth. Half of the company's revenue increase in 2024 came from new products. International growth is the third growth pillar, with overseas sales making up less than one-fifth of the company's total revenue. In comparison, other consumer product companies derive close to 60% of their sales internationally. These catalysts should enable Church & Dwight to continue posting healthy growth for many more years. Before you buy stock in Mastercard, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Mastercard wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Royston Yang has positions in Mastercard. The Motley Fool has positions in and recommends International Business Machines, Mastercard, and Microsoft. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Got $5,000? 3 Top Growth Stocks to Buy That Could Double Your Money. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
